Related Experiment Videos
Electron beam: the management of head and neck cancer
R R Million1, J T Parsons, F J Bova
1Department of Radiation Oncology, University of Florida College of Medicine, Gainesville.
Frontiers of Radiation Therapy and Oncology
|January 1, 1991
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Design and characterization of a prototype tertiary device for proton beam stereotactic radiosurgery.
Biomedical physics & engineering express·2021
Proton vs Hyperarc™ radiosurgery: A planning comparison.
Journal of applied clinical medical physics·2020
Novel MRI and CT compatible stereotactic brain biopsy system in dogs using patient-specific facemasks.
The Journal of small animal practice·2017
SRChing for the substrates of Src.
Oncogene·2013
Frameless stereotactic radiosurgery for the treatment of primary intracranial tumours in dogs.
Veterinary and comparative oncology·2013
The effect of temporal HU variations on the uncertainty of dose recalculations performed on MVCT images.
Physics in medicine and biology·2011
Proton therapy in the clinic.
Frontiers of radiation therapy and oncology·2011
Proton therapy: clinical gains through current and future treatment programs.
Frontiers of radiation therapy and oncology·2011
Stereotactic body radiotherapy for prostate cancer: current results of a phase II trial.
Frontiers of radiation therapy and oncology·2011
Stereotactic body radiation therapy for gastrointestinal malignancies.
Frontiers of radiation therapy and oncology·2011
Stereotactic body radiation therapy for thoracic cancers: recommendations for patient selection, setup and therapy.
Frontiers of radiation therapy and oncology·2011
Stereotactic body radiation therapy: normal tissue and tumor control effects with large dose per fraction.
Frontiers of radiation therapy and oncology·2011
Feasibility of Single-Session Whole-Liver Yttrium-90 Radioembolization for Multifocal Hepatocellular Carcinoma.
Korean journal of radiology·2026
Cemiplimab in cutaneous squamous cell carcinoma: a longer follow-up study focusing on the late toxicities.
Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG·2026
Not all anti-CD38 antibodies are created equal: The epitope of felzartamab is partially DTT-resistant.
Transfusion medicine (Oxford, England)·2026